Complete Story
04/20/2022
Attention Financial Navigators
Co-pay Assistance Program for Some Generic Medications!
KabiConnect is designed to increase access and lower out-of-pocket costs for eligible patients with financial needs
LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi announced today it has introduced KabiConnect, part of the KabiCare patient support program in the United States, to offer copay assistance for the company’s generic oncology medicines. Fresenius Kabi offers the most comprehensive portfolio of generic injectable oncology medicines in the U.S.
KabiConnect offers eligible patients financial support covering more than 30 different oncology medicines. The program can lower out-of-pocket costs to as little as $0 a month for eligible patients. To determine eligibility, patients should speak to their physician. Enrollment is a simple online process. Details can be found on the KabiCare website at kabicare.us
KabiCare U.S. Healthcare Provider Website
See Entire List of Generic Products Included in the KabiCare Patient Support Program
Report Broken Links
Have you encountered a problem with a URL (link) on this page not working or displaying an error message? Help us fix it!
